Study limitation: The 'practice changing' impact flag is applied cautiously — while results are clinically significant, confirmation in multicenter prospective studies is needed | ReachRx
Recompensation and Further Decompensation After Index Decompensation in Patients with Autoimmune Hepatitis: A Real-World Study
Study limitation reported by the research below: “The 'practice changing' impact flag is applied cautiously — while results are clinically significant, confirmation in multicenter prospective studies is needed.”